Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma.
Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma.
复制标题
DOI:
10.3390/biomedicines10030663
复制
发表时间:
2022-03-12
期刊:
影响因子:
4.7
通讯作者:
Seki N
中科院分区:
文献类型:
--
作者:
Asai S;Koma A;Nohata N;Kinoshita T;Kikkawa N;Kato M;Minemura C;Uzawa K;Hanazawa T;Seki N
Based on our original RNA sequence-based microRNA (miRNA) signatures of head and neck squamous cell carcinoma (HNSCC), it was revealed that the expression levels of miR-1-3p, miR-206, miR-133a-3p, and miR-133b were significantly suppressed in cancer specimens. Seed sequences of miR-1-3p/miR-206 and miR-133a-3p/miR-133b are identical. Interestingly, miR-1-3p/miR-133a-3p and miR-206/miR-133b are clustered in the human genome. We hypothesized that the genes coordinately controlled by these miRNAs are closely involved in the malignant transformation of HNSCC. Our in silico analysis identified a total of 28 genes that had putative miR-1-3p/miR-133a-3p and miR-206/miR-133b binding sites. Moreover, their expression levels were upregulated in HNSCC tissues. Multivariate Cox regression analyses showed that expression of PFN2 and PSEN1 were independent prognostic factors for patients with HNSCC (p < 0.05). Notably, four miRNAs (i.e., miR-1-3p, miR-206, miR-133a-3p, and miR-133b) directly bound the 3′untranslated region of PFN2 and controlled expression of the gene in HNSCC cells. Overexpression of PFN2 was confirmed in clinical specimens, and its aberrant expression facilitated cancer cell migration and invasion abilities. Our miRNA-based strategy continues to uncover novel genes closely involved in the oncogenesis of HNSCC.
登录
查看更多内容
影响因子:
5.2
作者:
Hozaka Y;Seki N;Tanaka T;Asai S;Moriya S;Idichi T;Wada M;Tanoue K;Kawasaki Y;Mataki Y;Kurahara H;Ohtsuka T
通讯作者:
Ohtsuka T
DOI:
10.1200/jco.20.02903
发表时间:
2021-06-10
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Ho AL;Brana I;Haddad R;Bauman J;Bible K;Oosting S;Wong DJ;Ahn MJ;Boni V;Even C;Fayette J;Flor MJ;Harrington K;Kim SB;Licitra L;Nixon I;Saba NF;Hackenberg S;Specenier P;Worden F;Balsara B;Leoni M;Martell B;Scholz C;Gualberto A
通讯作者:
Gualberto A
影响因子:
5.6
作者:
Kase-Kato I;Asai S;Minemura C;Tsuneizumi K;Oshima S;Koma A;Kasamatsu A;Hanazawa T;Uzawa K;Seki N
通讯作者:
Seki N
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
10
作者:
Kabekkodu, Shama P.;Shukla, Vaibhav;Satyamoorthy, Kapaettu
通讯作者:
Satyamoorthy, Kapaettu